Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment
Clinical trial NCT03672240 · COMPLETED
Trial details
- NCT number
- NCT03672240
- Sponsor
- Asieris Pharmaceutical Technologies Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-30
- Primary completion
- 2019-10-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.